SNDXSyndax Pharmaceuticals, Inc.

$2B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$21M

Net Income

-$20M

EPS (Diluted)

$-2.07

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$13M

Total Liabilities

$19M

Stockholders' Equity

-$6M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$21M	-$9M	-148.9%
Net Income	-$20M	-$14M	-39.9%

SNDX FY 2014 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena